Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study

Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study

BackgroundNeoadjuvant intraperitoneal and systemic chemotherapy (NIPS) has shown promising results in gastric cancer (GC) with peritoneal metastasis. However, clinical practice experience of NIPS is still lacking in China. In this study, we investigate the efficacy and safety of NIPS in Chinese pati...

Full description

Bibliographic Details
Main Authors: Zhong-Yin Yang, Fei Yuan, Sheng Lu, Wei Xu, Jun-Wei Wu, Wen-Qi Xi, Min Shi, Zhen-Qiang Wang, Zhen-Tian Ni, Chang-Yu He, Xue-Xin Yao, Ya-Nan Zheng, Zheng-Lun Zhu, Wen-Tao Liu, Jun Zhang, Huan Zhang, Chen Li, Chao Yan, Min Yan, Zheng-Gang Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
gastric cancer
peritoneal metastasis
intraperitoneal chemotherapy
paclitaxel
conversion surgery
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.905922/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.905922/full

Similar Items